☆ 4.7 Article

Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study

CLINICAL CANCER RESEARCH (2023)

Get Full Text
Add to Collection

Journal

CLINICAL CANCER RESEARCH
Volume -, Issue -, Pages OF1-OF11

Publisher

American Association for Cancer Research (AACR)
DOI: 10.1158/1078-0432.ccr-22-3915

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.